All Comments by John Olney

  1. Distribution of the messenger RNA for the extracellularly regulated kinases 1, 2 and 3 in rat brain: effects of excitotoxic hippocampal lesions.
  2. The role of the amyloid protein precursor (APP) in Alzheimer's disease: does the normal function of APP explain the topography of neurodegeneration?
  3. [Oxidative stress in the pathogenesis of Alzheimer's disease and antioxidant neuroprotection].
  4. Impaired calcium regulation in subcortical vascular encephalopathy.
  5. Impairment of glucose and glutamate transport and induction of mitochondrial oxidative stress and dysfunction in synaptosomes by amyloid beta-peptide: role of the lipid peroxidation product 4-hydroxynonenal.
  6. Involvement of neuronal anion exchange proteins in cell death in Alzheimer's disease.
  7. Alternative splicing of the glutamate transporter EAAT2 (GLT-1).
  8. Stable complexes involving acetylcholinesterase and amyloid-beta peptide change the biochemical properties of the enzyme and increase the neurotoxicity of Alzheimer's fibrils.
  9. Infracortical interstitial cells concurrently expressing m2-muscarinic receptors, acetylcholinesterase and nicotinamide adenine dinucleotide phosphate-diaphorase in the human and monkey cerebral cortex.
  10. Isoform-specific modulation by apolipoprotein E of the activities of secreted beta-amyloid precursor protein.
  11. Neurodegenerative disorders in humans: the role of glutathione in oxidative stress-mediated neuronal death.
  12. High affinity glutamate transporters: regulation of expression and activity.
  13. Psychotogenicity and N-methyl-D-aspartate receptor antagonism: implications for neuroprotective pharmacotherapy.
  14. Postnatal retinal ganglion cells in vitro: protection against reactive oxygen species (ROS)-induced axonal degeneration by cocultured astrocytes.
  15. A new paradigm for neurotoxicity by FAD mutants of betaAPP: a signaling abnormality.